267 related articles for article (PubMed ID: 17696172)
1. Disruption of cerebral cortex MET signaling in autism spectrum disorder.
Campbell DB; D'Oronzio R; Garbett K; Ebert PJ; Mirnics K; Levitt P; Persico AM
Ann Neurol; 2007 Sep; 62(3):243-50. PubMed ID: 17696172
[TBL] [Abstract][Full Text] [Related]
2. Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder.
Campbell DB; Li C; Sutcliffe JS; Persico AM; Levitt P
Autism Res; 2008 Jun; 1(3):159-68. PubMed ID: 19360663
[TBL] [Abstract][Full Text] [Related]
3. Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions.
Campbell DB; Buie TM; Winter H; Bauman M; Sutcliffe JS; Perrin JM; Levitt P
Pediatrics; 2009 Mar; 123(3):1018-24. PubMed ID: 19255034
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of the MET receptor tyrosine kinase gene by MeCP2 and sex-specific expression in autism and Rett syndrome.
Plummer JT; Evgrafov OV; Bergman MY; Friez M; Haiman CA; Levitt P; Aldinger KA
Transl Psychiatry; 2013 Oct; 3(10):e316. PubMed ID: 24150225
[TBL] [Abstract][Full Text] [Related]
5. A genetic variant that disrupts MET transcription is associated with autism.
Campbell DB; Sutcliffe JS; Ebert PJ; Militerni R; Bravaccio C; Trillo S; Elia M; Schneider C; Melmed R; Sacco R; Persico AM; Levitt P
Proc Natl Acad Sci U S A; 2006 Nov; 103(45):16834-9. PubMed ID: 17053076
[TBL] [Abstract][Full Text] [Related]
6. Further evidence that the rs1858830 C variant in the promoter region of the MET gene is associated with autistic disorder.
Jackson PB; Boccuto L; Skinner C; Collins JS; Neri G; Gurrieri F; Schwartz CE
Autism Res; 2009 Aug; 2(4):232-6. PubMed ID: 19681062
[TBL] [Abstract][Full Text] [Related]
7. The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders.
Levitt P; Campbell DB
J Clin Invest; 2009 Apr; 119(4):747-54. PubMed ID: 19339766
[TBL] [Abstract][Full Text] [Related]
8. MET and autism susceptibility: family and case-control studies.
Sousa I; Clark TG; Toma C; Kobayashi K; Choma M; Holt R; Sykes NH; Lamb JA; Bailey AJ; Battaglia A; Maestrini E; Monaco AP;
Eur J Hum Genet; 2009 Jun; 17(6):749-58. PubMed ID: 19002214
[TBL] [Abstract][Full Text] [Related]
9. Regulation of MET by FOXP2, genes implicated in higher cognitive dysfunction and autism risk.
Mukamel Z; Konopka G; Wexler E; Osborn GE; Dong H; Bergman MY; Levitt P; Geschwind DH
J Neurosci; 2011 Aug; 31(32):11437-42. PubMed ID: 21832174
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), and their receptors in human breast cells and tissues: alternative receptors.
Wilson SE; Weng J; Chwang EL; Gollahon L; Leitch AM; Shay JW
Cell Mol Biol Res; 1994; 40(4):337-50. PubMed ID: 7866434
[TBL] [Abstract][Full Text] [Related]
11. Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression.
Beviglia L; Matsumoto K; Lin CS; Ziober BL; Kramer RH
Int J Cancer; 1997 Jun; 74(3):301-9. PubMed ID: 9221809
[TBL] [Abstract][Full Text] [Related]
12. Met receptor signaling: a key effector in esophageal adenocarcinoma.
Anderson MR; Harrison R; Atherfold PA; Campbell MJ; Darnton SJ; Obszynska J; Jankowski JA
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5936-43. PubMed ID: 17062664
[TBL] [Abstract][Full Text] [Related]
13. The autism-associated MET receptor tyrosine kinase engages early neuronal growth mechanism and controls glutamatergic circuits development in the forebrain.
Peng Y; Lu Z; Li G; Piechowicz M; Anderson M; Uddin Y; Wu J; Qiu S
Mol Psychiatry; 2016 Jul; 21(7):925-35. PubMed ID: 26728565
[TBL] [Abstract][Full Text] [Related]
14. Association of a MET genetic variant with autism-associated maternal autoantibodies to fetal brain proteins and cytokine expression.
Heuer L; Braunschweig D; Ashwood P; Van de Water J; Campbell DB
Transl Psychiatry; 2011 Oct; 1(10):e48. PubMed ID: 22833194
[TBL] [Abstract][Full Text] [Related]
15. Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain.
Jung W; Castren E; Odenthal M; Vande Woude GF; Ishii T; Dienes HP; Lindholm D; Schirmacher P
J Cell Biol; 1994 Jul; 126(2):485-94. PubMed ID: 8034747
[TBL] [Abstract][Full Text] [Related]
16. An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma.
Kongkham PN; Northcott PA; Ra YS; Nakahara Y; Mainprize TG; Croul SE; Smith CA; Taylor MD; Rutka JT
Cancer Res; 2008 Dec; 68(23):9945-53. PubMed ID: 19047176
[TBL] [Abstract][Full Text] [Related]
17. Gene expressions of c-met and hepatocyte growth factor in chronic liver disease and hepatocellular carcinoma.
Noguchi O; Enomoto N; Ikeda T; Kobayashi F; Marumo F; Sato C
J Hepatol; 1996 Mar; 24(3):286-92. PubMed ID: 8778194
[TBL] [Abstract][Full Text] [Related]
18. The Involvement of Hepatocyte Growth Factor-MET-Matrix Metalloproteinase 1 Signaling in Bladder Cancer Invasiveness and Proliferation. Effect of the MET Inhibitor, Cabozantinib (XL184), on Bladder Cancer Cells.
Shintani T; Kusuhara Y; Daizumoto K; Dondoo TO; Yamamoto H; Mori H; Fukawa T; Nakatsuji H; Fukumori T; Takahashi M; Kanayama H
Urology; 2017 Mar; 101():169.e7-169.e13. PubMed ID: 28013036
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
[TBL] [Abstract][Full Text] [Related]
20. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells.
Harrington LS; Sainson RC; Williams CK; Taylor JM; Shi W; Li JL; Harris AL
Microvasc Res; 2008 Mar; 75(2):144-54. PubMed ID: 17692341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
